Tekla Life Sciences Investors
(NYSE:HQL)
$12.38
-0.01[-0.08%]
Last update: 7:00PM (Delayed 15-Minutes)
Get Real Time Here
$12.35
-0.0300[-0.24%]
Open12.350Close12.380
Vol / Avg.84.796K / 92.069KMkt Cap324.505M
Day Range12.350 - 12.48452 Wk Range12.250 - 15.240

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Tekla Life Sciences Invts Stock (NYSE:HQL), Key Statistics

Tekla Life Sciences Invts Stock (NYSE: HQL) analysis, key statistics.

Valuation Measures
Enterprise Value
- -
Trailing P/E
123.9
Forward P/E
- -
PE Ratio (TTM)
123.9
PEG Ratio (TTM)
- -
Price / Sales (ttm)
47.68
Price / Book (mrq)
0.77
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
0.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.12
Tangible Book value per share
16.12
Total Liabilities (Quarterly)
10M
Total Assets
432.7M
Total Liabilities
10M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -